Ruane, Cunniff & Goldfarb — ELV Trade History
Quarter-by-quarter changes in the ELEVANCE HEALTH INC FORMERLY position · CUSIP 036752103
Currently held · 5.5 YearsFirst seen: 2021 Q1
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Reduce | 979,598 | -408,370 | -29.4% | $378.8M | 5.89% |
| 2026 Q1 | 2026-05-15 | Reduce | 1,387,968 | -34,538 | -2.4% | $406.3M | 6.74% |
| 2025 Q4 | 2026-02-13 | Reduce | 1,422,506 | -25,777 | -1.8% | $498.7M | 7.79% |
| 2025 Q3 | 2025-11-14 | Add | 1,448,283 | 352,628 | +32.2% | $468.0M | 7.75% |
| 2025 Q2 | 2025-08-14 | Reduce | 1,095,655 | -27,265 | -2.4% | $426.2M | 7.31% |
| 2025 Q1 | 2025-05-15 | Reduce | 1,122,920 | -21,033 | -1.8% | $488.4M | 8.87% |
| 2024 Q4 | 2025-02-14 | Add | 1,143,953 | 139,420 | +13.9% | $422.0M | 7.17% |
| 2024 Q3 | 2024-11-14 | Reduce | 1,004,533 | -19,538 | -1.9% | $522.4M | 8.17% |
| 2024 Q2 | 2024-08-14 | Reduce | 1,024,071 | -50,614 | -4.7% | $554.9M | 8.65% |
| 2024 Q1 | 2024-05-15 | Reduce | 1,074,685 | -46,958 | -4.2% | $557.3M | 8.65% |
| 2023 Q4 | 2024-02-14 | Reduce | 1,121,643 | -28,578 | -2.5% | $528.9M | 8.45% |
| 2023 Q3 | 2023-11-14 | Add | 1,150,221 | 101,573 | +9.7% | $500.8M | 8.31% |
| 2023 Q2 | 2023-08-14 | Add | 1,048,648 | 241,524 | +29.9% | $465.9M | 7.35% |
| 2023 Q1 | 2023-05-15 | Reduce | 807,124 | -19,399 | -2.3% | $371.1M | 6.06% |
| 2022 Q4 | 2023-02-13 | Reduce | 826,523 | -161,334 | -16.3% | $424.0M | 6.62% |
| 2022 Q3 | 2022-11-14 | Reduce | 987,857 | -26,130 | -2.6% | $448.7M | 6.67% |
| 2022 Q2 | 2022-08-15 | Reduce | 1,013,987 | -743,441 | -42.3% | $489.3M | 6.38% |
| 2022 Q1 | 2022-05-13 | Reduce | 1,757,428 | -12,612 | -0.7% | $863.3M | 8.50% |
| 2021 Q4 | 2022-02-14 | Reduce | 1,770,040 | -51,373 | -2.8% | $820.5M | 7.01% |
| 2021 Q3 | 2021-11-15 | Reduce | 1,821,413 | -22,588 | -1.2% | $679.0M | 6.10% |
| 2021 Q2 | 2021-08-16 | Add | 1,844,001 | 672,156 | +57.4% | $704.0M | 6.24% |
| 2021 Q1 | 2021-05-17 | New | 1,171,845 | 1,171,845 | — | $420.6M | 3.96% |
| 2020 Q4 | 2021-02-16 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-16 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-14 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-15 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-14 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-14 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-14 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-15 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-14 | — | — | — | — | — | — |
| 2018 Q2 | 2018-08-14 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-15 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.